glaucoma

Applying micropulse transscleral cyclophotocoagulation for early-stage glaucoma Micropulse transscleral cyclophotocoagulation utilises a different delivery modality than its predecessor, continuous-wave laser cycloablation, to produce a biological reaction without the lethal effects caused by thermal buildup.
Applying hydrogel technology to sustained-release ocular drugsHydrogel technology enables the use of drugs that are known to be efficacious for ocular diseases and conditions when formulated as daily drops or monthly injections, into one-time or several-month dosage forms.
P.S. Use this cost-effective marketing tactic to increase end-of-year profitsWhen you do not have enough money or time, a well-worded post script can be your best friend. Whether you are the new doctor who doesn’t have a large database or the kind-hearted provider who accepts all those low-paying plans and really can’t afford the estimated 60 cents per unit cost of a fall postcard campaign, please consider adding a P.S. to emails and a red-ink P.S. to all patient-directed, routine postal pieces.
Engaging OCTA in glaucoma imaging
Engaging OCTA in glaucoma imagingA prospective, observational study found that eyes with mild POAG could be differentiated from pre-perimetric glaucomatous eyes, which also could be differentiated from normal eyes using OCTA-derived retinal vessel density measurements.
Study explores influence of ocular blood flow in course of glaucomaOcular blood flow has been associated with the incidence, prevalence and progression of glaucoma, but its potential causative role remains a subject for debate. Better insights may be on the horizon using OCT angiography and sophisticated mathematical modeling techniques.
Adding electroretinography: Technology to clinical utilityPattern electroretinography (PERG) and visually evoked potential (VEP) tests can objectively evaluate the function of axion and retinal ganglion cells. These test results can add another component in successfully treating patients with cataract and/or glaucoma.
Aqueous angiography: Moving toward individualized IOP control
Aqueous angiography: Moving toward individualized IOP controlAqueous angiography facilitates increased understanding of aqueous humor outflow that can provide individualized treatment for IOP control.
ARMOR surveillance study update gives current insights on antibiotic resistance for clinical ocular isolatesThe most recent analyses of data from the ARMOR (Antibiotic Resistance Monitoring in Ocular micRoorganisms) Surveillance Program can guide clinicians choosing antibiotic therapy for initial empiric therapy and infection prophylaxis. The information also reinforces the importance of prudent antibiotic prescribing to limit the development of bacterial resistance to existing options, according to Penny Asbell, MD.
Glaucoma patients' gender plays a role in treatmentsLouise A. Sclafani, OD, FAAO, talks about the different concerns with men and women when diagnosing and treating glaucoma patients at Vision Expo West in Las Vegas, NV.
Exploring wider role for premium IOL implantation in glaucoma patientsWhen it comes to recommending a premium IOL, a patient’s glaucoma is only one factor to consider. Just like any other patient planning cataract surgery, visual needs and preferences for/against glasses are also important factors.